• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Korea·Consumer Cyclical·200130.KQ
Share

KOLMAR BNH Co.,Ltd. Stocks

₩ 8410Last Updated 28.07.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

₩ 162.44M

₩ 8410
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Kolmar BNH Co., Ltd., a South Korean entity, dedicates its efforts to the research and development of cosmetics, health-enhancing functional foods, and advanced functional ingredients, serving both domestic and international markets. Their extensive product portfolio encompasses vitamins and minerals, weight management solutions, sports and nutritional supplements, gut health formulations, and various other offerings tailored for both men and women. Founded in 2004, the company was initially known as Sun Bio Tech before rebranding as Kolmar BNH Co., Ltd. in 2013. Headquartered in Sejong, South Korea, it operates as a subsidiary of Kolmar Korea Holdings Co., Ltd.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA, reasona

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.07.2026 16:24

Iran and Oman are negotiating the reopening of the Strait of Hormuz. Brent crude is down 2%.

28.07.2026 15:39

Morning in New York: Investors Need New Signals

28.07.2026 15:12

Shares of a small-cap company developing a treatment for vitiligo have skyrocketed. A competitor wants to buy it.

28.07.2026 13:47

An Nvidia employee was detained in Taiwan in connection with a case involving the smuggling of AI chips to China

28.07.2026 12:29

Samsung and SK Hynix Plummeted Ahead of Earnings Reports: News from China Fueled Investor Fears

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026